Yufei Pan
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- RNA modifications and cancer 5
- Surgery 17
- Cholangiocarcinoma and Gallbladder Cancer Studies 13
- Co-authors
- Liwei Dong (27 shared papers)Yexiong Tan (24 shared papers)Hongyang Wang (21 shared papers)Tianyi Jiang (15 shared papers)Guang-Zhen Yang (6 shared papers)Zhiwen Ding (8 shared papers)Yun‐Kai Lin (10 shared papers)Chun Yang (9 shared papers)
- Journals
- Cancer Letters (3 papers)Frontiers in Immunology (2 papers)Annals of Oncology (2 papers)Cell Death and Disease (2 papers)Hepatology (2 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Yufei Pan
38 papers receiving 876 citations
Peers
Comparison fields: 5 of 91
- Cancer Research 191
- Oncology 179
- Molecular Biology 431
- Hepatology 47
- Immunology 113
Countries citing papers authored by Yufei Pan
This map shows the geographic impact of Yufei Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yufei Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yufei Pan more than expected).
Fields of papers citing papers by Yufei Pan
This network shows the impact of papers produced by Yufei Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yufei Pan. The network helps show where Yufei Pan may publish in the future.
Co-authors
The 25 scholars most cited alongside Yufei Pan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 67 | |
| 2 | 2011 | 58 | |
| 3 | 2016 | 54 | |
| 4 | 2013 | 51 | |
| 5 | 2023 | 51 | |
| 6 | 2023 | 49 | |
| 7 | 2020 | 40 | |
| 8 | 2011 | 39 | |
| 9 | 2016 | 39 | |
| 10 | 2013 | 37 | |
| 11 | 2014 | 36 | |
| 12 | 2020 | 34 | |
| 13 | 2015 | 32 | |
| 14 | 2024 | 30 | |
| 15 | 2024 | 28 | |
| 16 | 2018 | 26 | |
| 17 | 2013 | 24 | |
| 18 | 2014 | 21 | |
| 19 | 2023 | 20 | |
| 20 | 2019 | 20 |
About Yufei Pan
Yufei Pan is a scholar working on Molecular Biology, Surgery, Oncology, Cancer Research and Immunology, having authored 47 papers that have together received 892 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (13 papers), RNA modifications and cancer (5 papers), Peptidase Inhibition and Analysis (5 papers), Nanoplatforms for cancer theranostics (3 papers), Cancer, Lipids, and Metabolism (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cancer Mechanisms and Therapy (3 papers) and Ferroptosis and cancer prognosis (3 papers). The work is most often cited by research in Cancer Research (191 citations), Oncology (179 citations), Molecular Biology (431 citations), Hepatology (47 citations) and Immunology (113 citations). Yufei Pan has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Liwei Dong, Yexiong Tan, Hongyang Wang, Tianyi Jiang, Guang-Zhen Yang, Zhiwen Ding, Yun‐Kai Lin, Chun Yang, Jian Zhang and Liang Tang. Their work appears in journals such as Cancer Letters, Frontiers in Immunology, Annals of Oncology, Cell Death and Disease and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.